Today: 30 June 2026
Browse Category

NASDAQ:SNSE 5 December 2025

Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast

Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast

Sensei Biotherapeutics, Inc. has suddenly landed back on traders’ radars. After months of drifting as a tiny, cash‑rich micro‑cap biotech, the stock exploded higher at the start of December 2025 – just weeks after the company killed its lead drug program and launched a strategic review. This article walks through the latest SNSE stock price moves, the full 2025 news timeline, the strategic review, analyst forecasts, and the key risks around this highly speculative name. It is informational only and not investment advice.
5 December 2025
··

Stock Market Today

  • Celestica Inc. (CLS) Draws Market Interest on AI, Energy Momentum
    June 30, 2026, 5:53 AM EDT. Celestica Inc. (CLS) has beaten Nvidia's gains over the past three years as demand from artificial intelligence (AI) and energy transition pushes growth. Shares sit about 20% below all-time highs and the Zacks price target as the stock faces some pressure. The company is guiding for double-digit sales and earnings growth in 2025 and 2026, pointing to strong revenues on the back of demand from data centers, semiconductors and energy storage markets. Celestica's operations split into Advanced Technology Solutions and Connectivity & Cloud Solutions, covering design, manufacturing and logistics. CEO Rob Mionis said demand remains solid and flagged new AI program wins, mentioning a 1.6 terabyte switching project with a hyperscaler. CLS trades at a discount to the Zacks Tech Sector, which bulls call attractive for buy-and-hold tech investors.
Go toTop